Key terms
About LYEL
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LYEL news
No recent news articles are available for LYEL
No recent press releases are available for LYEL
LYEL Financials
Key terms
Ad Feedback
LYEL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LYEL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range